Confirmatory clinical trial of Liwen RF™ ablation system in China concluded

HANGZHOU, China, March 4, 2023 /PRNewswire/ — On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF™ ablation system developed by the Company has successfully enrolled one patient at West China…